Nasopharyngeal Carcinoma (NPC) Axitinib

Summary

This is an open-label, single arm, phase 2 clinical trial evaluating the activity and safety of single-agent axitinib in recurrent or metastatic NPC patients who failed at least one line of platinum based chemotherapy.

Timeline

Start

2010-12

Primary completion

2016-12

Completion

2016-12

Drugs

Indications